HealthWatch with Dick Haefner

Sept. 30, 2024 ~ Interventional cardiologist and Medical Director of Heart and Vascular Services at Henry Ford Health System, Dr. Herbert Aronow, M.D., addresses the rising concerns surrounding erythritol, an artificial sweetener linked to an increased risk of blood clots, heart attacks, and strokes. Despite the long-term effects of this sweetener are unknown and the FDA deems it g

Sept. 30, 2024 ~ Interventional cardiologist and Medical Director of Heart and Vascular Services at Henry Ford Health System, Dr. Herbert Aronow, M.D., addresses the rising concerns surrounding erythritol, an artificial sweetener linked to an increased risk of blood clots, heart attacks, and strokes. Despite the long-term effects of this sweetener are unknown and the FDA deems it g

Sept. 30, 2024 ~ Interventional cardiologist and Medical Director of Heart and Vascular Services at Henry Ford Health System, Dr. Herbert Aronow, M.D., addresses the rising concerns surrounding erythritol, an artificial sweetener linked to an increased risk of blood clots, heart attacks, and strokes. Despite the long-term effects of this sweetener are unknown and the FDA deems it g

Sept. 30, 2024 ~ Interventional cardiologist and Medical Director of Heart and Vascular Services at Henry Ford Health System, Dr. Herbert Aronow, M.D., addresses the rising concerns surrounding erythritol, an artificial sweetener linked to an increased risk of blood clots, heart attacks, and strokes. Despite the long-term effects of this sweetener are unknown and the FDA deems it g

Sept. 5, 2024 ~ Dr. Anthony Chang, founder and CEO of BAMF Health, the world’s first integrated platform that merges molecular imaging with radiopharmaceutical therapy, talks about theranostics as an emerging concept in cancer care. This approach utilizes molecular imaging to locate and identify tumors, determining if a patient is a suitable match for specific treatments and the

Sept. 5, 2024 ~ Dr. Anthony Chang, founder and CEO of BAMF Health, the world’s first integrated platform that merges molecular imaging with radiopharmaceutical therapy, talks about theranostics as an emerging concept in cancer care. This approach utilizes molecular imaging to locate and identify tumors, determining if a patient is a suitable match for specific treatments and the

Sept. 5, 2024 ~ Dr. Anthony Chang, founder and CEO of BAMF Health, the world’s first integrated platform that merges molecular imaging with radiopharmaceutical therapy, talks about theranostics as an emerging concept in cancer care. This approach utilizes molecular imaging to locate and identify tumors, determining if a patient is a suitable match for specific treatments and the

Sept. 5, 2024 ~ Dr. Anthony Chang, founder and CEO of BAMF Health, the world’s first integrated platform that merges molecular imaging with radiopharmaceutical therapy, talks about theranostics as an emerging concept in cancer care. This approach utilizes molecular imaging to locate and identify tumors, determining if a patient is a suitable match for specific treatments and the

Aug. 8, 2024 ~ Dr. Jason Novetski of Champion Mindset Group talks about the mental and emotional challenges that young athletes face, and the ways in which sport performance psychology coaching can help overcome these issues. The approach uses therapy, group sessions, and more to help athletes learn mental toughness, growth mindset, and emotional control techniques, all designed to

Aug. 8, 2024 ~ Dr. Jason Novetski of Champion Mindset Group talks about the mental and emotional challenges that young athletes face, and the ways in which sport performance psychology coaching can help overcome these issues. The approach uses therapy, group sessions, and more to help athletes learn mental toughness, growth mindset, and emotional control techniques, all designed to